In August 2014, Safeguard Scientifics led New York City fintech company Transactis’ $11 million Series D.
Eighteen months later, the Radnor-based venture firm has again invested in the company, this time with five major U.S. banks, in a $30 million Series E. Safeguard’s co-investors are Capital One, Fifth Third, TD, PNC and Wells Fargo.
Safeguard CEO Stephen Zarrilli and partner Phil Moyer are both board members of the electronic billing company.
Companies:
Safeguard Scientifics
Join our growing Slack community
Join 5,000 tech professionals and entrepreneurs in our community Slack today!
Donate to the Journalism Fund
Your support powers our independent journalism. Unlike most business-media outlets, we don’t have a paywall. Instead, we count on your personal and organizational contributions.